These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 16101428)

  • 1. Hydroxyimine NO-donors; FK409 and derivatives.
    Yoshida K; Kita Y
    Curr Top Med Chem; 2005; 5(7):675-85. PubMed ID: 16101428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of FK409, a novel nitric oxide donor, on acute experimental myocardial ischemia.
    Isono T; Sato N; Koibuchi Y; Sakai S; Yamamoto T; Ozaki R; Mori J; Kohsaka M; Ohtsuka M
    Jpn J Pharmacol; 1993 Jul; 62(3):315-24. PubMed ID: 8411778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of FK409 on small bowel ischemia-reperfusion injury in dogs.
    Kawata K; Takeyoshi I; Iwanami K; Sunose Y; Aiba M; Ohwada S; Matsumoto K; Morishita Y
    Transplant Proc; 2001; 33(1-2):883. PubMed ID: 11267113
    [No Abstract]   [Full Text] [Related]  

  • 4. Spontaneous nitric oxide release accounts for the potent pharmacological actions of FK409.
    Kita Y; Hirasawa Y; Maeda K; Nishio M; Yoshida K
    Eur J Pharmacol; 1994 May; 257(1-2):123-30. PubMed ID: 8082692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effects of FK409, a novel nitric oxide donor, against postischemic myocardial dysfunction in guinea-pig hearts.
    Cao Y; Hotta Y; Shioi K; Nagata Y; Kawai N; Ishikawa N
    J Cardiovasc Pharmacol; 2001 Oct; 38(4):593-605. PubMed ID: 11588530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerance to the vascular effect of a novel nitric oxide-donating vasodilator, FK409.
    Isono T; Sato N; Yamamoto T; Sawada T; Yamazaki S; Miura S; Furuichi A; Ozaki R; Koibuchi Y; Ohtsuka M
    Eur J Pharmacol; 1994 Aug; 260(2-3):163-8. PubMed ID: 7988640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel nitric oxide donor (FK409) ameliorates liver damage during extended liver resection with warm ischemia in dogs.
    Aiba M; Takeyoshi I; Ohwada S; Kawashima Y; Iwanami K; Sunose Y; Yamada T; Tsutsumi H; Matsumoto K; Morishita Y
    J Am Coll Surg; 2001 Sep; 193(3):264-71. PubMed ID: 11548796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antianginal effects of FK409, a new spontaneous NO releaser.
    Kita Y; Ozaki R; Sakai S; Sugimoto T; Hirasawa Y; Ohtsuka M; Senoh H; Yoshida K; Maeda K
    Br J Pharmacol; 1994 Dec; 113(4):1137-40. PubMed ID: 7889266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the effects of the novel vasodilator FK409 with those of nitroglycerin in isolated coronary artery of the dog.
    Yamada H; Yoneyama F; Satoh K; Taira N
    Br J Pharmacol; 1991 Jul; 103(3):1713-8. PubMed ID: 1681975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardioprotective effects of FK409, a nitric oxide donor, after isolated rat heart preservation for 16 hours.
    Zhang JM; Orihashi K; Sueda T; Matsuura Y
    Ann Thorac Surg; 2000 Nov; 70(5):1601-6. PubMed ID: 11093494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic mechanisms of the antianginal action of a novel vasodilator FK409 in dynamic exercise-induced angina.
    Yokota M; Matsunami T; Kodama Y; Sobue T; Nishinaka Y; Iwase M; Miyahara T; Koide M; Saito H; Shibata S
    J Cardiovasc Pharmacol; 1993 Mar; 21(3):412-22. PubMed ID: 7681502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationships of spontaneous nitric oxide releasers, FK409 and its derivatives.
    Fukuyama S; Hirasawa Y; Kato Y; Nishio M; Ohno M; Nishino S; Maeda K; Kato M; Kita Y
    J Pharmacol Exp Ther; 1997 Jul; 282(1):236-42. PubMed ID: 9223559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasorelaxant mechanism of the new vasodilator, FK409.
    Isono T; Koibuchi Y; Sato N; Furuichi A; Nishii M; Yamamoto T; Mori J; Kohsaka M; Ohtsuka M
    Eur J Pharmacol; 1993 Aug; 246(3):205-12. PubMed ID: 7901040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new nitric oxide (NO) releaser: spontaneous NO release from FK409.
    Fukuyama S; Kita Y; Hirasawa Y; Azuma T; Sato A; Morokoshi N; Koda S; Yasuda T; Oka S; Sakurai H
    Free Radic Res; 1995 Nov; 23(5):443-52. PubMed ID: 7581827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuation of canine warm ischemic small bowel injury by novel combination of nitric oxide donor, FK409, and cytokine suppressive anti-inflammatory agent FR167653.
    Totsuka E; Murata A; Nishimura A; Umehara M; Nara M; Ono H; Nozaki T; Takiguchi M; Wajima N; Takahashi K; Seino K; Narumi S; Hakamada K; Sasaki M
    Transplant Proc; 2004 Sep; 36(7):1988-90. PubMed ID: 15518720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FR144420, a novel, slow, nitric oxide-releasing agent.
    Kita Y; Ohkubo K; Hirasawa Y; Katayama Y; Ohno M; Nishino S; Kato M; Yoshida K
    Eur J Pharmacol; 1995 Mar; 275(2):125-30. PubMed ID: 7796846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of pre- and post-ischemic treatments with FK409, a nitric oxide donor, on ischemia/reperfusion-induced renal injury and endothelin-1 production in rats.
    Nakajima A; Ueda K; Takaoka M; Kurata H; Takayama J; Ohkita M; Matsumura Y
    Biol Pharm Bull; 2006 Mar; 29(3):577-9. PubMed ID: 16508172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FK409 inhibits both local and remote organ damage after intestinal ischaemia.
    Kalia N; Brown NJ; Hopkinson K; Stephenson TJ; Wood RF; Pockley AG
    J Pathol; 2002 Aug; 197(5):595-602. PubMed ID: 12210078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of FK409 on pulmonary ischemia-reperfusion injury in dogs.
    Tanahashi Y; Takeyoshi I; Aiba M; Ohwada S; Matsumoto K; Morishita Y
    Transpl Int; 1999; 12(6):402-7. PubMed ID: 10654350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of the vasorelaxing action of (3E)-4-ethyl-2-hydroximino-5-nitro-3-hexamide FK409, a new vasodilator isolated from microbial sources, in isolated rabbit arteries.
    Shibata S; Satake N; Sato N; Matsuo M; Koibuchi Y; Hester RK
    J Cardiovasc Pharmacol; 1991 Mar; 17(3):508-18. PubMed ID: 1711615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.